135 related articles for article (PubMed ID: 9589471)
41. Decreased immunoexpression of prostate inhibin peptide in prostatic carcinoma: a study with monoclonal antibody.
Zhang PJ; Driscoll DL; Lee HK; Nolan C; Velagapudi SR
Hum Pathol; 1999 Feb; 30(2):168-72. PubMed ID: 10029444
[TBL] [Abstract][Full Text] [Related]
42. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
Zeng L; Rowland RG; Lele SM; Kyprianou N
Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
[TBL] [Abstract][Full Text] [Related]
43. Expression of some selected cytokeratins and Ki67 protein in prostatic tumor: can these be used as tumor markers.
Adisa JO; Egbujo EC; Ibrahim B; Musa B; Madukwe J
Pan Afr Med J; 2015; 20():46. PubMed ID: 26090004
[TBL] [Abstract][Full Text] [Related]
44. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.
Chen G; Shukeir N; Potti A; Sircar K; Aprikian A; Goltzman D; Rabbani SA
Cancer; 2004 Sep; 101(6):1345-56. PubMed ID: 15316903
[TBL] [Abstract][Full Text] [Related]
45. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
[TBL] [Abstract][Full Text] [Related]
46. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases.
Bostwick DG; Qian J; Maihle NJ
Prostate; 2004 Feb; 58(2):164-8. PubMed ID: 14716741
[TBL] [Abstract][Full Text] [Related]
47. Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer.
Jerónimo C; Henrique R; Oliveira J; Lobo F; Pais I; Teixeira MR; Lopes C
J Clin Pathol; 2004 Aug; 57(8):872-6. PubMed ID: 15280411
[TBL] [Abstract][Full Text] [Related]
48. Lymphatic vessel density in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer assessed in whole-mount sections.
Longatto-Filho A; Malheiro LF; Milanezi F; Pinheiro C; Baltazar F; Schmitt FC; Montironi R
Anal Quant Cytol Histol; 2009 Oct; 31(5):269-75. PubMed ID: 20701093
[TBL] [Abstract][Full Text] [Related]
49. Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases.
Friess H; Guo XZ; Berberat P; Graber HU; Zimmermann A; Korc M; Büchler MW
Int J Cancer; 1998 Aug; 79(4):349-55. PubMed ID: 9699525
[TBL] [Abstract][Full Text] [Related]
50. Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissue.
Kitamura H; Torigoe T; Asanuma H; Hisasue SI; Suzuki K; Tsukamoto T; Satoh M; Sato N
Histopathology; 2006 Jan; 48(2):157-61. PubMed ID: 16405664
[TBL] [Abstract][Full Text] [Related]
51. CD40 is not detected on human prostate cancer cells by immunohistologic techniques.
Moghaddami M; Cohen P; Stapleton AM; Brown MP
Urology; 2001 Mar; 57(3):573-8. PubMed ID: 11248650
[TBL] [Abstract][Full Text] [Related]
52. IL-6, IL-10 and HSP-90 expression in tissue microarrays from human prostate cancer assessed by computer-assisted image analysis.
Cardillo MR; Ippoliti F
Anticancer Res; 2006; 26(5A):3409-16. PubMed ID: 17094460
[TBL] [Abstract][Full Text] [Related]
53. Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy.
Coogan CL; Bostwick DG; Bloom KJ; Gould VE
Urology; 2003 Jan; 61(1):248-52. PubMed ID: 12559317
[TBL] [Abstract][Full Text] [Related]
54. KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells.
Marreiros A; Dudgeon K; Dao V; Grimm MO; Czolij R; Crossley M; Jackson P
Oncogene; 2005 Jan; 24(4):637-49. PubMed ID: 15580298
[TBL] [Abstract][Full Text] [Related]
55. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
[TBL] [Abstract][Full Text] [Related]
56. Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis.
Erdamar S; Yang G; Harper JW; Lu X; Kattan MW; Thompson TC; Wheeler TM
Mod Pathol; 1999 Aug; 12(8):751-5. PubMed ID: 10463475
[TBL] [Abstract][Full Text] [Related]
57. Differential expression of MSX2 in nodular hyperplasia, high-grade prostatic intraepithelial neoplasia and prostate adenocarcinoma.
Chua CW; Chiu YT; Yuen HF; Chan KW; Wang X; Ling MT; Wong YC
APMIS; 2010 Dec; 118(12):918-26. PubMed ID: 21091772
[TBL] [Abstract][Full Text] [Related]
58. Expression of the KAI1 metastasis suppressor gene in non-metastatic versus metastatic human colorectal cancer.
Yang JL; Jackson P; Yu Y; Russell PJ; Markovic B; Crowe PJ
Anticancer Res; 2002; 22(6A):3337-42. PubMed ID: 12530084
[TBL] [Abstract][Full Text] [Related]
59. Relationship between expression of KAI1 metastasis suppressor gene, mRNA levels and p53 in human bladder and prostate cancer cell lines.
Jackson P; Grimm MO; Kingsley EA; Brosius U; Antalis T; Yardley G; Russell PJ
Urol Oncol; 2002; 7(3):99-104. PubMed ID: 12474542
[TBL] [Abstract][Full Text] [Related]
60. Metallothionein isoform II expression in hyperplastic, dysplastic and neoplastic prostatic lesions.
El Sharkawy SL; Abbas NF; Badawi MA; El Shaer MA
J Clin Pathol; 2006 Nov; 59(11):1171-4. PubMed ID: 16574721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
